-
1
-
-
0035025073
-
A 33-year follow-up of narcotics addicts
-
Hser YI, Hoffman V, Grella CE, et al. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58:503-508. (Pubitemid 32411332)
-
(2001)
Archives of General Psychiatry
, vol.58
, Issue.5
, pp. 503-508
-
-
Hser, Y.-I.1
Hoffman, V.2
Grella, C.E.3
Anglin, M.D.4
-
2
-
-
33749527209
-
Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN)
-
Fischer B, Cruz MF, Rehm J. Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry. 2006;51:624-634. (Pubitemid 44526424)
-
(2006)
Canadian Journal of Psychiatry
, vol.51
, Issue.10
, pp. 624-634
-
-
Fischer, B.1
Cruz, M.F.2
Rehm, J.3
-
3
-
-
56749170122
-
Health-related quality of life in HIV-infected patients: The role of substance use
-
Korthuis PT, Zephyrin LC, Fleishman JA, et al. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDs. 2008;22:859-867.
-
(2008)
AIDS Patient Care STDs
, vol.22
, pp. 859-867
-
-
Korthuis, P.T.1
Zephyrin, L.C.2
Fleishman, J.A.3
-
4
-
-
29744440510
-
The characteristics of heroin users entering treatment: Findings from the Australian treatment outcome study (ATOS)
-
DOI 10.1080/09595230500286039, PII R37477382285
-
Ross J, Teesson M, Darke S, et al. The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev. 2005;24:411-418. (Pubitemid 43024040)
-
(2005)
Drug and Alcohol Review
, vol.24
, Issue.5
, pp. 411-418
-
-
Ross, J.1
Teesson, M.2
Darke, S.3
Lynskey, M.4
Ali, R.5
Ritter, A.6
Cooke, R.7
-
5
-
-
33748750443
-
Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain
-
DOI 10.1089/aid.2006.22.715
-
Rodriguez-Arenas MA, Jarrin I, del Amo J, et al. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain. AIDS Res Hum Retroviruses. 2006;22:715-723. (Pubitemid 44734997)
-
(2006)
AIDS Research and Human Retroviruses
, vol.22
, Issue.8
, pp. 715-723
-
-
Rodriguez-Arenas, M.A.1
Jarrin, I.2
Del Amo, J.3
Iribarren, J.A.4
Moreno, S.5
Viciana, P.6
Pena, A.7
Sirvent, J.L.G.8
Vidal, F.9
Lacruz, J.10
Gutierrez, F.11
Oteo, J.A.12
Asencio, R.13
Castilla, J.14
Hoyos, S.P.15
-
6
-
-
36849077593
-
The impact of illicit drug use and substance abuse treatment on adherence to HAART
-
DOI 10.1080/09540120701351888, PII 787839925
-
Hicks PL, Mulvey KP, Chander G, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19: 1134-1140. (Pubitemid 350223192)
-
(2007)
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
, vol.19
, Issue.9
, pp. 1134-1140
-
-
Hicks, P.L.1
Mulvey, K.P.2
Chander, G.3
Fleishman, J.A.4
Josephs, J.S.5
Korthuis, P.T.6
Hellinger, J.7
Gaist, P.8
Gebo, K.A.9
-
7
-
-
50149103758
-
Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users
-
Wood E, Kerr T, Zhang R, et al. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. HIV Med. 2008;9:503-507.
-
(2008)
HIV Med
, vol.9
, pp. 503-507
-
-
Wood, E.1
Kerr, T.2
Zhang, R.3
-
8
-
-
61649126283
-
Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders
-
Mellins CA, Havens JF, McDonnell C, et al. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care. 2009;21:168-177.
-
(2009)
AIDS Care
, vol.21
, pp. 168-177
-
-
Mellins, C.A.1
Havens, J.F.2
McDonnell, C.3
-
9
-
-
38149128055
-
Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use
-
Shannon K, Kerr T, Lai C, et al. Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use. J Int Assoc Physicians AIDS Care (Chic Ill). 2005;4:66-72.
-
(2005)
J Int Assoc Physicians AIDS Care (Chic Ill)
, vol.4
, pp. 66-72
-
-
Shannon, K.1
Kerr, T.2
Lai, C.3
-
10
-
-
0036500139
-
HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: Relationship with outpatient care patterns
-
Laine C, Zhang D, Hauck WW, et al. HIV-1 RNA viral load monitoring in HIV-infected drug users on antiretroviral therapy: relationship with outpatient care patterns. J Acquir Immune Defic Syndr. 2002;29:270-274. (Pubitemid 34208535)
-
(2002)
Journal of Acquired Immune Deficiency Syndromes
, vol.29
, Issue.3
, pp. 270-274
-
-
Laine, C.1
Zhang, D.2
Hauck, W.W.3
Turner, B.J.4
-
11
-
-
58149149647
-
Variations in sexual risks in drug users: Emerging themes in a behavioral context
-
Celentano DD, Latimore AD, Mehta SH. Variations in sexual risks in drug users: emerging themes in a behavioral context. Curr HIV/AIDS Rep. 2008;5:212-218.
-
(2008)
Curr HIV/AIDS Rep
, vol.5
, pp. 212-218
-
-
Celentano, D.D.1
Latimore, A.D.2
Mehta, S.H.3
-
12
-
-
64049112057
-
HIV-associated behaviors among injecting-drug users-23 cities, United States, May 2005- February 2006
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. HIV-associated behaviors among injecting-drug users-23 cities, United States, May 2005- February 2006. MMWR Morbid Mortal Wkly Rep. 2009;58:329-332.
-
(2009)
MMWR Morbid Mortal Wkly Rep
, vol.58
, pp. 329-332
-
-
-
13
-
-
33746326187
-
Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy
-
DOI 10.1016/j.drugalcdep.2006.02.003, PII S0376871606000603
-
Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006; 84:188-194. (Pubitemid 44119095)
-
(2006)
Drug and Alcohol Dependence
, vol.84
, Issue.2
, pp. 188-194
-
-
Palepu, A.1
Tyndall, M.W.2
Joy, R.3
Kerr, T.4
Wood, E.5
Press, N.6
Hogg, R.S.7
Montaner, J.S.G.8
-
14
-
-
0033735921
-
Methadone maintenance treatment (MMT): A review of historical and clinical issues
-
Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med. 2000; 67:347-364.
-
(2000)
Mt Sinai J Med
, vol.67
, pp. 347-364
-
-
Joseph, H.1
Stancliff, S.2
Langrod, J.3
-
15
-
-
0036951539
-
Beliefs about methadone in an inner-city methadone clinic
-
DOI 10.1093/jurban/79.4.571
-
Stancliff S, Myers JE, Steiner S, et al. Beliefs about methadone in an inner-city methadone clinic. J Urban Health. 2002;79:571-578. (Pubitemid 36076530)
-
(2002)
Journal of Urban Health
, vol.79
, Issue.4
, pp. 571-578
-
-
Stancliff, S.1
Myers, J.E.2
Steiner, S.3
Drucker, E.4
-
16
-
-
0031967641
-
The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis
-
Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93:515-532. (Pubitemid 28188071)
-
(1998)
Addiction
, vol.93
, Issue.4
, pp. 515-532
-
-
Marsch, L.A.1
-
17
-
-
51149102685
-
Attitudes toward buprenorphine and methadone among opioid-dependent individuals
-
Schwartz RP, Kelly SM, O'Grady KE, et al. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am J Addict. 2008;17:396-401.
-
(2008)
Am J Addict
, vol.17
, pp. 396-401
-
-
Schwartz, R.P.1
Kelly, S.M.2
O'Grady, K.E.3
-
18
-
-
27644479567
-
The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?
-
DOI 10.1016/j.drugalcdep.2004.12.008
-
Sullivan LE, Chawarski M, O'Connor PG, et al. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? Drug Alcohol Depend. 2005;79: 113-116. (Pubitemid 41557130)
-
(2005)
Drug and Alcohol Dependence
, vol.79
, Issue.1
, pp. 113-116
-
-
Sullivan, L.E.1
Chawarski, M.2
O'Connor, P.G.3
Schottenfeld, R.S.4
Fiellin, D.A.5
-
19
-
-
46249094214
-
Pharmacogenetic treatments for drug addiction: Alcohol and opiates
-
DOI 10.1080/00952990802122564, PII 793256422
-
Haile CN, Kosten TA, Kosten TR. Pharmacogenetic treatments for drug addiction: alcohol and opiates. Am J Drug Alcohol Abuse. 2008;34: 355-381. (Pubitemid 351913747)
-
(2008)
American Journal of Drug and Alcohol Abuse
, vol.34
, Issue.4
, pp. 355-381
-
-
Haile, C.N.1
Kosten, T.A.2
Kosten, T.R.3
-
20
-
-
43449109822
-
Narrative review: Buprenorphine for opioid-dependent patients in office practice
-
Sullivan LE, Fiellin DA. Narrative review: buprenorphine for opioid-dependent patients in office practice. Ann Intern Med. 2008;148:662-670. (Pubitemid 351669111)
-
(2008)
Annals of Internal Medicine
, vol.148
, Issue.9
, pp. 662-670
-
-
Sullivan, L.E.1
Fiellin, D.A.2
-
22
-
-
35248870244
-
Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients
-
DOI 10.1016/j.jsat.2006.11.009, PII S0740547206003692
-
Maremmani I, Pani PP, Pacini M, et al. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-related heroin-addicted patients. J Subst Abuse Treat. 2007;33:91-98. (Pubitemid 350198612)
-
(2007)
Journal of Substance Abuse Treatment
, vol.33
, Issue.1
, pp. 91-98
-
-
Maremmani, I.1
Pani, P.P.2
Pacini, M.3
Perugi, G.4
-
23
-
-
0034597736
-
A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence
-
Johnson RE, Chutuape MA, Strain EC, et al. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000;343:1290-1297.
-
(2000)
N Engl J Med
, vol.343
, pp. 1290-1297
-
-
Johnson, R.E.1
Chutuape, M.A.2
Strain, E.C.3
-
24
-
-
0042360208
-
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone
-
DOI 10.1056/NEJMoa022164
-
Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949-958. (Pubitemid 37064768)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.10
, pp. 949-958
-
-
Fudala, P.J.1
Bridge, T.P.2
Herbert, S.3
Williford, W.O.4
Chiang, C.N.5
Jones, K.6
Collins, J.7
Raisch, D.8
Casadonte, P.9
Goldsmith, R.J.10
Ling, W.11
Malkerneker, U.12
McNicholas, L.13
Renner, J.14
Stine, S.15
Tusel, D.16
-
25
-
-
0037987958
-
Clinical efficacy of buprenorphine: Comparisons to methadone and placebo
-
DOI 10.1016/S0376-8716(03)00059-0
-
Ling W, Wesson DR. Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend. 2003;70:S49-S57. (Pubitemid 36556060)
-
(2003)
Drug and Alcohol Dependence
, vol.70
, Issue.2 SUPPL.
-
-
Ling, W.1
Wesson, D.R.2
-
27
-
-
0038325744
-
From morphine clinics to buprenorphine: Regulating opioid agonist treatment of addiction in the United States
-
DOI 10.1016/S0376-8716(03)00055-3
-
Jaffe JH, O'Keeffe C. From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States. Drug Alcohol Depend. 2003;70:S3-S11. (Pubitemid 36556056)
-
(2003)
Drug and Alcohol Dependence
, vol.70
, Issue.2 SUPPL.
-
-
Jaffe, J.H.1
O'Keeffe, C.2
-
28
-
-
79951781216
-
A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care
-
Cheever L, Kresina TF, Cajina A, et al. A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S3-S6.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Cheever, L.1
Kresina, T.F.2
Cajina, A.3
-
29
-
-
79951779992
-
Integration of buprenorphine/ naloxone treatment into HIV clinical care: Lessons from the BHIVES collaborative
-
Weiss L, Netherland J, Egan JE, et al. Integration of buprenorphine/ naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S1-S2.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Weiss, L.1
Netherland, J.2
Egan, J.E.3
-
30
-
-
79951792799
-
Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/ naloxone and HIV care
-
Chaudhry AA, Botsko M, Weiss L, et al. Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/ naloxone and HIV care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1): S14-S21.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Chaudhry, A.A.1
Botsko, M.2
Weiss, L.3
-
31
-
-
79951802471
-
Improving adherence to HIV quality of care indicators in persons with opioid dependence: The role of buprenorphine/naloxone
-
Korthuis PT, Fiellin DA, Rongwei F, et al. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011;56(Suppl 1): S83-S90.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Korthuis, P.T.1
Fiellin, D.A.2
Rongwei, F.3
-
32
-
-
79951802651
-
The cost of integrated HIV care and buprenorphine/naloxone treatment: Results of a cross-site evaluation
-
Schackman BS, Leff J, Botsko M, et al. The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S76-S82.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Schackman, B.S.1
Leff, J.2
Botsko, M.3
-
33
-
-
79951782548
-
Drug treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone
-
Fiellin DA, Weiss L, Botsko M, et al. Drug treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S33-S38.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Fiellin, D.A.1
Weiss, L.2
Botsko, M.3
-
34
-
-
79951791597
-
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone
-
Sullivan LE, Botsko M, Cunningham C, et al. The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S54-S61.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Sullivan, L.E.1
Botsko, M.2
Cunningham, C.3
-
35
-
-
79951775696
-
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study
-
Altice FL, Lucas GM, Lum P, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S22-S32.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Altice, F.L.1
Lucas, G.M.2
Lum, P.3
-
36
-
-
79951792603
-
Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients
-
Vergara-Rodriguez P, Tozzi MJ, Botsko M, et al. Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients. J Acquir Immune Defic Syndr. 2011;56(Suppl 1): S62-S67.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Vergara-Rodriguez, P.1
Tozzi, M.J.2
Botsko, M.3
-
37
-
-
79951782715
-
Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care
-
Egan JE, Netherland J, Gass J, et al. Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S46-S53.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Egan, J.E.1
Netherland, J.2
Gass, J.3
-
38
-
-
79951792248
-
Policy implications of integrating buprenorphine/naloxone treatment and HIV care
-
Finkelstein R, Netherland J, Sylla L, et al. Policy implications of integrating buprenorphine/naloxone treatment and HIV care. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S98-S104.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Finkelstein, R.1
Netherland, J.2
Sylla, L.3
-
39
-
-
79951805433
-
Opioid prescribing and provider confidence recognizing opioid abuse in HIV primary care settings
-
Lum PJ, Little S, Botsko M, et al. Opioid prescribing and provider confidence recognizing opioid abuse in HIV primary care settings. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S91-S97.
-
(2011)
J Acquir Immune Defic Syndr.
, vol.56
, Issue.SUPPL. 1
-
-
Lum, P.J.1
Little, S.2
Botsko, M.3
-
40
-
-
18744436804
-
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project
-
DOI 10.1016/S0895-4356(98)00109-7, PII S0895435698001097
-
Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1171-1178. (Pubitemid 28527173)
-
(1998)
Journal of Clinical Epidemiology
, vol.51
, Issue.11
, pp. 1171-1178
-
-
Gandek, B.1
Ware, J.E.2
Aaronson, N.K.3
Apolone, G.4
Bjorner, J.B.5
Brazier, J.E.6
Bullinger, M.7
Kaasa, S.8
Leplege, A.9
Prieto, L.10
Sullivan, M.11
-
41
-
-
0018899363
-
An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index
-
DOI 10.1097/00005053-198001000-00006
-
McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33. (Pubitemid 10187569)
-
(1980)
Journal of Nervous and Mental Disease
, vol.168
, Issue.1
, pp. 26-33
-
-
McLellan, A.T.1
Luborsky, L.2
Woody, G.E.3
O'Brien, C.P.4
-
42
-
-
61349160477
-
Factors affecting willingness to provide buprenorphine treatment
-
Netherland J, Botsko M, Egan JE, et al. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009;36:244-251.
-
(2009)
J Subst Abuse Treat
, vol.36
, pp. 244-251
-
-
Netherland, J.1
Botsko, M.2
Egan, J.E.3
-
43
-
-
0020959111
-
The Brief Symptom Inventory: An introductory report
-
Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13:595-605. (Pubitemid 13019024)
-
(1983)
Psychological Medicine
, vol.13
, Issue.3
, pp. 595-605
-
-
Derogatis, L.R.1
Melisaratos, N.2
|